RT Journal Article
SR Electronic
T1 Non-invasive vagus nerve stimulation conditions increased invigoration and wanting in depression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.28.23296284
DO 10.1101/2023.09.28.23296284
A1 Ferstl, Magdalena
A1 Kühnel, Anne
A1 Klaus, Johannes
A1 Lin, Wy Ming
A1 Kroemer, Nils B.
YR 2023
UL http://medrxiv.org/content/early/2023/09/29/2023.09.28.23296284.abstract
AB Background Major depressive disorder (MDD) is often marked by impaired motivation and reward processing, known as anhedonia. Many patients do not respond to first-line treatments, and improvements in motivation can be slow, creating an urgent need for rapid interventions. Recently, we demonstrated that transcutaneous auricular vagus nerve stimulation (taVNS) acutely boosts effort invigoration in healthy participants, but its effects on depression remain unclear.Objective To assess the impact of taVNS on effort invigoration and maintenance in a sample that includes patients with MDD, evaluating the generalizability of our findings.Methods We used a single-blind, randomized crossover design in 30 patients with MDD and 29 matched (age, sex, and BMI) healthy control participants (HCP).Results Consistent with prior findings, taVNS increased effort invigoration for rewards in both groups during Session 1 (p=.040), particularly for less wanted rewards in HCP (pboot<.001). However, invigoration remained elevated in all participants, and no acute changes were observed in Session 2 (Δinvigoration=3.52, p=.093). Crucially, throughout Session 1, we found taVNS-induced increases in effort invigoration (pboot =.008) and wanting (pboot=.010) in patients with MDD, with gains in wanting maintained across sessions (Δwanting=0.06, p=.97).Conclusions Our study replicates the invigorating effects of taVNS in Session 1 and reveals its generalizability to depression. Furthermore, we expand upon previous research by showing taVNS-induced conditioning effects on invigoration and wanting within Session 1 in patients that were largely sustained. While enduring motivational improvements present challenges for crossover designs, they are highly desirable in interventions and warrant further follow-up research.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT05120336Funding StatementThe study was supported by the University of Tuebingen, Faculty of Medicine fortune grant 2453-0-0, Daimler & Benz Foundation 32-04/19, and the Deutsche Forschungsgemeinschaft (DFG), grants KR 4555/7-1, KR 4555/9-1, & KR 4555/10-1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committee of the medical faculty of the university of Tuebingen.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets used during the current study are available from the corresponding author on reasonable request.